News Wire

In what has been called a possible game-changing development in health care, the Department of Justice today approved of Cigna’s proposed purchase of the biggest PBM in the country, Express Scripts.

The New England Journal of Medicine (NEJM) describes the recent brouhaha over a paper it published a dispute that the author H. Gilbert Welch, MD, and the two researchers who claim Welch plagiarized them must settle on their own.

Well, here’s a real eye-opener for you: Getting a needle in the eye. Sure, it makes you flinch, but for millions of Medicare beneficiaries getting an injection of Eylea can help them retain vision.

First, the good news. There’s been a recent stock market rally for generic drug manufacturers. The bad news, even after the rally, shares for Teva Pharmaceutical Industries are down nearly 70% from a 2015 high. Mylan shares are down about 50% since then.

The FDA approved Cassipa (buprenorphine and naloxone) sublingual film for the maintenance treatment of opioid dependence. This action provides a new dosage strength (16 milligrams/4 milligrams) of buprenorphine and naloxone sublingual film, which is also approved in both brand name and generic versions and in various strengths.

In the aftermath of hundreds of lawsuits over the years against pharmaceutical giant Purdue Pharma, Colorado’s attorney general is now suing the OxyContin creator for what it calls its “significant role in causing the opioid epidemic.”

A new fast-acting flu drug, baloxavir marboxil (Xofluza, Shinogi), reduced the length of time that people were sick with flu symptoms by a little over a day, according to two recently published clinical trials that were reported in the New England Journal of Medicine (NEJM).

A new study published in Nature Biotechnology reports that experimental software trained on recordings from seven patients with brain implants can decode variations in mood.

Heavy-hitting players in the hospital industry—including Intermountain Healthcare, the Mayo Clinic, and HCA Healthcare—felt that they had little choice but to ban together to fix what they consider a flawed supply chain for generic medications, says Dan Liljenquist, a vice president at Intermountain who initiated the project.

The most extensive analysis ever of metastatic tumors has dredged up hope for cancer patients and their physicians. Metastatic cancer can travel from the primary tumor to everywhere in the body and scientists have long believed that the metastasis in, say, the lungs is genetically different from the metastasis in, say, the liver.

This year the national average for premium hikes in ACA health plans was a whopping 30%. Next year, according to an analysis by the AP and Avalere Health, it will dip dramatically to 3.6% across 47 states and Washington, D.C. For an individual covered under the ACA, the total average premium will be close to $600 a month before subsidies.

The FDA is warning consumers and health care professionals about a voluntary recall of one lot of Montelukast Sodium Tablets – lot number MON17384, expiration 12/31/2019 – by Camber Pharmaceuticals, Inc., in Piscataway, N.J.

The U.S. District Court for the District of New Jersey entered an order of permanent injunction against S Hackett Marketing LLC doing business as Just Enhance; R Thomas Marketing LLC; Shawn Hackett, president and owner of Just Enhance; and Roger Thomas, president and founder of R Thomas Marketing LLC.

China’s equivalent of the U.S. FDA is expected in the coming days to approve fruquintinib, the leading drug from Chinese drug maker Chi-Med, for patients with advanced colon cancer who have already tried two or more chemotherapies.

Drug-resistant bacteria caused nearly 6 percent of urinary tract infections (UTIs) studied by a California emergency department, a new study reports.

The bacteria were resistant to a majority of commonly used antibiotics and many of the patients had no identifiable risk factors for this kind of infection.

Pages